Testing Nishauri app for HIV treatment in men
Part of Infections clinical trials.
This study tests a smartphone-based support tool called Nishauri to see if it helps men stick with HIV treatment. It may be a good fit if you're a man living with HIV and have a smartphone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are male.
- You own a smartphone or tablet.
- You are between 18 and 55 years old.
- You are willing to take part and give written permission (informed consent).
- You do not have a serious mental or chronic illness that could affect your participation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a mobile health app or text-based tool can help young people with HIV stay on top of their treatment and medical appointments. The goal is to make it easier to manage HIV care using your phone.
This study tests a program called Motivation Matters! to help people with HIV who have traded sex for things they need get started on HIV medication and stay healthy. It uses text messages to support you.
This study tests whether helping men with HIV who also drink heavily can lower their alcohol use and improve how well HIV treatment works to prevent passing the virus to others. It's for men living in fishing communities in Uganda.
This study tests a phone/computer-based peer support program to help women with HIV improve how consistently they take their HIV medicine (ART). It may help if you’ve had trouble meeting your medication schedule recently and you’re eligible to safely participate.
This trial tests an mHealth (phone-based) program to help women with HIV improve health outcomes. It targets people who have had recent challenges with clinic visits, detectable virus levels, or taking HIV medicines.
This study tests a smartphone program to help young men who have sex with men stay healthy and prevent HIV. It's designed for people already getting care at certain clinics.
Hear when a new HIV Antiretroviral Therapy (ART) Adherence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.